Journal of Nutrition Animal Diets/Enrichment Products...

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition Vol. 125 No. 6_Suppl June 1995, pp. 1699-1703
Copyright © 1995 by American Society for Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khoury, R. S.
Right arrow Articles by Farach-Carson, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khoury, R. S.
Right arrow Articles by Farach-Carson, M. C.

Vitamin D Metabolites Modulate Osteoblast Activity by Ca+2 Influx-Independent Genomic and Ca+2 Influx-Dependent Nongenomic Pathways1,2,

Ramzi S. Khoury, Jean Weber and Mary C. Farach-Carson3

The University of Texas - Houston, Health Science Center, Dental Branch, Department of Basic Sciences, Section of Biochemistry, Houston, TX 77030

Previous studies have shown that 1,25(OH)2D3 activates multiple signaling pathways in osteoblasts, including rapid nongenomic and long-term genomic pathways. Genomic pathways are mediated by the vitamin D receptor (VDR), a member of the steroid receptor superfamily, and involve transcriptional regulation of target genes. Nongenomic pathways involve lipid turnover, activation of Ca+2 channels and elevation of intracellular Ca+2, all of which occur within seconds after addition of seco-steroid. The interaction of other physiological metabolites of vitamin D, such as 24,25(OH)2D3, with target cells such as osteoblasts is much less clear. We have used a combination of electrophysiological, biochemical, molecular and ion tracer studies to dissect the physiological responses of osteoblast-like osteosarcoma cells (ROS 17/2.8) to 1,25(OH)2D3 and related metabolites. We conclude the following: 1) the structural requirements for activation of genomic vs. nongenomic pathways by seco-steroid are distinct and likely to involve separate receptors; 2) activation of rapid nongenomic pathways is independent of the long-term regulation of target genes; and 3) 1,25(OH)2D3 and 24,25(OH)2D3 interact at the level of the plasma membrane to regulate Ca+2 permeability. Present studies are aimed toward the understanding of the role of both genomic and nongenomic pathways in osteoblast physiology.


KEY WORDS: • osteoblasts • vitamin D metabolites • calcium influx • bone

1 Presented as part of the symposium "Pleiotropic Actions of Vitamin D" given at the Experimental Biology '94 meeting, Anaheim, CA, on April 26, 1994. This symposium was sponsored by the American Institute of Nutrition. Guest editor for this symposium was Anthony W. Norman, University of California, Riverside, CA.

2 Supported by DE-10318.

3 To whom correspondence should be addressed: Department of Basic Sciences, Section of Biochemistry, University of Texas—Houston, Dental Branch, DBB 3.108, 6516 John Freeman Ave., Houston, TX 77030.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. S. Dusso, A. J. Brown, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F8 - F28.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]